Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2019 · 10-Q
Revenue$7.54B$7.54B+2.0% vs Q1 2018 Net Income$672.00M$672.00M+60.8% vs Q1 2018 EPS Diluted$0.38$0.38+65.2% vs Q1 2018 Gross Profit$3,889,000,000+4.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flow$712,000,000−35.7% Free Cash Flowderived$377,000,000−54.7% Margins · derivedGross margin51.6%+1.0 pt vs Q1 2018
Operating margin9.8%+1.6 pt vs Q1 2018
Net margin8.9%+3.3 pt vs Q1 2018
ended Mar 31, 2019 · filed May 1, 2019 · 31 d after period end